Check Twice! Recall Issued for Mislabeled Birth Control Pills, FDA Warns Mistake Could Result in Pregnancy

The Federal Drug Administration has announced a recall on Mibelas 24 Fe, a brand of birth control pills that was placed in their packages in the wrong order and can result in an unwanted pregnancy.

The brand accidently reversed the sequence of its powerful hormone and placebo pills.

via NYDN:

The company that produces them, Lupin Pharmaceuticals, is voluntarily recalling the drug.

The packaging for the chewable contraceptive includes 24 active hormone pills of estradiol — a form of estrogen key in preventing ovulation —and four placebos to be taken at the end of the user’s birth control cycle.

And even though the active pills are differently colors from the placebos — white for the hormones and brown for the others — the FDA says users run the risk of becoming confused without the proper labeling.

The pills were distributed nationwide.

Drugs impacted by the recall can be identified two different ways: they either have the lot number “L600518” and an expiration date of May 2018 or a fuzzy or blank listing for both.

This latest contraceptive kerfuffle comes less than a year after a separate birth control pill recall. In 2016, 1.3 million Gildess Fe birth control pills were pulled back by the pharmaceutical giant Pantheon for not having enough estradiol in each dose.

If you or anyone you know uses Mibelas 24 Fe, check the packaging before you come home with a surprise announcement.

Share This Post